Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-06-043259
Filing Date
2006-06-23
Accepted
2006-06-22 20:05:25
Documents
4
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-14174_110ka.htm 10-K/A 155659
2 EX-23 a06-14174_1ex23d1.htm EX-23.1 2304
3 EX-31 a06-14174_1ex31d1.htm EX-31.1 4248
4 EX-31 a06-14174_1ex31d2.htm EX-31.2 4247
  Complete submission text file 0001104659-06-043259.txt   167901
Mailing Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453
Business Address 51 SAWYER ROAD SUITE 200 WALTHAM MA 02453 7816473900
INVERNESS MEDICAL INNOVATIONS INC (Filer) CIK: 0001145460 (see all company filings)

EIN.: 043565120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-16789 | Film No.: 06920757
SIC: 2835 In Vitro & In Vivo Diagnostic Substances